Bio-Techne (BSP:T1CH34) Long-Term Debt : R$1,937 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Long-Term Debt?

Bio-Techne's Long-Term Debt for the quarter that ended in Mar. 2024 was R$1,937 Mil.

Bio-Techne's quarterly Long-Term Debt increased from Sep. 2023 (R$2,173 Mil) to Dec. 2023 (R$2,190 Mil) but then declined from Dec. 2023 (R$2,190 Mil) to Mar. 2024 (R$1,937 Mil).

Bio-Techne's annual Long-Term Debt declined from Jun. 2021 (R$1,654 Mil) to Jun. 2022 (R$1,229 Mil) but then increased from Jun. 2022 (R$1,229 Mil) to Jun. 2023 (R$1,699 Mil).

Bio-Techne Long-Term Debt Historical Data

The historical data trend for Bio-Techne's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Long-Term Debt Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

1,899.55

1,786.07

1,653.51

1,228.66

1,698.80

Bio-Techne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															1,927.18	1,698.80	2,173.03	2,190.21	1,937.14

Bio-Techne (BSP:T1CH34) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bio-Techne Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne (BSP:T1CH34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines